Bacterial Outer Membrane Vesicles Loaded with Perhexiline Suppress Tumor Development by Regulating Tumor-Associated Macrophages Repolarization in a Synergistic Way
暂无分享,去创建一个
Jufang Wang | Yi Ma | Shoujin Jiang | Wei Fu | Guanshu Zhu | Sijia Wang
[1] C. Dandara,et al. The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited , 2023, Cancers.
[2] Tae Kon Kim,et al. Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities , 2022, Nature Reviews Drug Discovery.
[3] Yue Zhang,et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer , 2022, Cell.
[4] F. Balkwill,et al. Harnessing cytokines and chemokines for cancer therapy , 2022, Nature Reviews Clinical Oncology.
[5] O. Mir,et al. Modulating tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors: A TAM-pting approach. , 2021, Pharmacology & therapeutics.
[6] Qinjun Chen,et al. Sequentially Triggered Bacterial Outer Membrane Vesicles for Macrophage Metabolism Modulation and Tumor Metastasis Suppression. , 2021, ACS nano.
[7] Wen Yin,et al. Cancer and stem cells , 2021, Experimental biology and medicine.
[8] J. Joyce,et al. Therapeutic Targeting of the Tumor Microenvironment. , 2021, Cancer discovery.
[9] T. Daemen,et al. Re-polarization of immunosuppressive macrophages to tumor-cytotoxic macrophages by repurposed metabolic drugs , 2021, Oncoimmunology.
[10] N. Ajami,et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients , 2020, Science.
[11] Yujing Li,et al. Bacterial Outer Membrane Vesicles Presenting Programmed Death 1 for Improved Cancer Immunotherapy via Immune Activation and Checkpoint Inhibition. , 2020, ACS nano.
[12] Xiaohong Li,et al. Bacterial ghosts for targeting delivery and subsequent responsive release of ciprofloxacin to destruct intracellular bacteria , 2020 .
[13] Shuang Wang,et al. Biomineralized Bacterial Outer Membrane Vesicles Potentiate Safe and Efficient Tumor Microenvironment Reprogramming for Anticancer Therapy , 2020, Advanced materials.
[14] A. Selman,et al. Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells , 2020, Pharmaceuticals.
[15] Tianzhi Huang,et al. Stem cell programs in cancer initiation, progression, and therapy resistance , 2020, Theranostics.
[16] Yucai Wang,et al. Bacterial outer membrane vesicles as a platform for biomedical applications: An update. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[17] K. Dzobo,et al. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic. , 2020, Omics : a journal of integrative biology.
[18] Guojun Huang,et al. Bioengineering Bacterial Vesicle-Coated Polymeric Nanomedicine for Enhanced Cancer Immunotherapy and Metastasis Prevention. , 2019, Nano letters.
[19] Sejin Oh,et al. Invariant NKT cells facilitate cytotoxic T-cell activation via direct recognition of CD1d on T cells , 2019, Experimental & Molecular Medicine.
[20] Brian Ruffell,et al. Macrophages as regulators of tumour immunity and immunotherapy , 2019, Nature Reviews Immunology.
[21] D. Wink,et al. Molecular Mechanisms of Nitric Oxide in Cancer Progression, Signal Transduction, and Metabolism. , 2019, Antioxidants & redox signaling.
[22] Wen-Chao Liu,et al. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors , 2018, Cell Death & Disease.
[23] M. Netea,et al. Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship. , 2018, Cancer letters.
[24] Jiri Bartek,et al. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adapter NPL4 , 2017, Nature.
[25] N. E. Thomford,et al. The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer , 2017, International journal of molecular sciences.
[26] Heather H Gustafson,et al. Progress in tumor-associated macrophage (TAM)-targeted therapeutics. , 2017, Advanced drug delivery reviews.
[27] J. Boucher,et al. TLR4/IFNγ pathways induce tumor regression via NOS II-dependent NO and ROS production in murine breast cancer models , 2016, Oncoimmunology.
[28] F. Ossendorp,et al. Combinatorial prospects of nano-targeted chemoimmunotherapy. , 2016, Biomaterials.
[29] M. Kuehn,et al. Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions , 2015, Nature Reviews Microbiology.
[30] Abhishek K. Jha,et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. , 2015, Immunity.
[31] Vipul Gujrati,et al. Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy. , 2014, ACS nano.
[32] Ali Khademhosseini,et al. Biocompatibility of engineered nanoparticles for drug delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[33] Reiko Nishihara,et al. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. , 2012, The New England journal of medicine.
[34] P. De Baetselier,et al. Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions. , 2011, The International journal of developmental biology.
[35] Jeffrey W. Pollard,et al. Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.
[36] J. Karp,et al. Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .
[37] P. Aavitsland,et al. Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease. , 2007, Vaccine.
[38] J. Horowitz,et al. Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone. , 1996, Biochemical pharmacology.
[39] A. Nissle. [Explanations of the significance of colonic dysbacteria & the mechanism of action of E. coli therapy (mutaflor)]. , 1959, Die Medizinische.